Defective N‐glycosylation in tumor‐infiltrating CD8+ T cells impairs IFN‐γ‐mediated effector function

T cell-mediated antitumor immunity is modulated, in part, by N-glycosylation. However, the interplay between N-glycosylation and the loss of effector function in exhausted T cells has not yet been fully investigated. Here, we delineated the impact of N-glycosylation on the exhaustion of tumor-infiltrating lymphocytes in a murine colon adenocarcinoma model, focusing on the IFN-γ-mediated immune response. We found that exhausted CD8+ T cells downregulated the oligosaccharyltransferase complex, which is indispensable for N-glycan transfer. Concordant N-glycosylation deficiency in tumor-infiltrating lymphocytes leads to loss of antitumor immunity. Complementing the oligosaccharyltransferase complex restored IFN-γ production and alleviated CD8+ T cell exhaustion, resulting in reduced tumor growth. Thus, aberrant glycosylation induced in the tumor microenvironment incapacitates effector CD8+ T cells. Our findings provide insights into CD8+ T cell exhaustion by incorporating N-glycosylation to understand the characteristic loss of IFN-γ, opening new opportunities to amend the glycosylation status in cancer immunotherapies.

[1]  S. Pinho,et al.  Glycans as shapers of tumour microenvironment: A sweet driver of T‐cell‐mediated anti‐tumour immune response , 2022, Immunology.

[2]  S. Tu,et al.  Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments , 2021, Frontiers in Immunology.

[3]  J. Reymond,et al.  Substrate specificities and reaction kinetics of the yeast oligosaccharyltransferase isoforms , 2021, The Journal of biological chemistry.

[4]  R. Kiessling,et al.  Counteracting CAR T cell dysfunction , 2020, Oncogene.

[5]  W. Lee,et al.  Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity , 2020, Experimental & Molecular Medicine.

[6]  S. Erkeland,et al.  Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation , 2020, PLoS pathogens.

[7]  N. Callewaert,et al.  Human T cell glycosylation and implications on immune therapy for cancer , 2020, Human vaccines & immunotherapeutics.

[8]  X. Liu,et al.  Large-scale public data reuse to model immunotherapy response and resistance , 2020, Genome Medicine.

[9]  T. Toyofuku,et al.  Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells , 2020, The Journal of Immunology.

[10]  N. Taniguchi,et al.  Oligosaccharyltransferase: A Gatekeeper of Health and Tumor Progression , 2019, International journal of molecular sciences.

[11]  Chen Yan,et al.  IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer , 2019, BMC Cancer.

[12]  S. Berger,et al.  TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion , 2019, Nature.

[13]  E. Wherry,et al.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.

[14]  M. Kalady,et al.  Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. , 2019, Cell metabolism.

[15]  S. Pinho,et al.  Glycans as Key Checkpoints of T Cell Activity and Function , 2018, Front. Immunol..

[16]  G. Rabinovich,et al.  IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity , 2018, Nature.

[17]  X. Liu,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[18]  D. Maresch,et al.  An oligosaccharyltransferase from Leishmania major increases the N‐glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana , 2018, Plant biotechnology journal.

[19]  Morihisa Fujita,et al.  Construction of green fluorescence protein mutant to monitor STT3B‐dependent N‐glycosylation , 2018, The FEBS journal.

[20]  R. Vijay,et al.  Interleukin‐10 Directly Inhibits CD8+ T Cell Function by Enhancing N‐Glycan Branching to Decrease Antigen Sensitivity , 2018, Immunity.

[21]  J. Whisstock,et al.  Regulation of perforin activation and pre‐synaptic toxicity through C‐terminal glycosylation , 2017, EMBO reports.

[22]  A. Yoshimura,et al.  Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells. , 2017, Cell reports.

[23]  I. Frazer,et al.  Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity , 2017, Cell Death & Disease.

[24]  M. Pereira,et al.  Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction , 2017, Cellular Physiology and Biochemistry.

[25]  J. Wargo,et al.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.

[26]  R. Schreiber,et al.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.

[27]  Young Hwan Kim,et al.  Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. , 2015, Carbohydrate research.

[28]  A. Antebi,et al.  Hexosamine pathway and (ER) protein quality control. , 2015, Current opinion in cell biology.

[29]  H. Freeze,et al.  Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. , 2013, Human molecular genetics.

[30]  H. Freeze,et al.  A sensitive green fluorescent protein biomarker of N‐glycosylation site occupancy , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  P. Walter,et al.  The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.

[32]  Christodoulos A. Floudas,et al.  Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database , 2011, Scientific reports.

[33]  L. Harrington,et al.  Pronounced Virus-Dependent Activation Drives Exhaustion but Sustains IFN-γ Transcript Levels , 2010, The Journal of Immunology.

[34]  Luis Serrano,et al.  Correlation of mRNA and protein in complex biological samples , 2009, FEBS letters.

[35]  Temple F. Smith,et al.  Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses , 2009, Proceedings of the National Academy of Sciences.

[36]  S. High,et al.  Ribophorin I regulates substrate delivery to the oligosaccharyltransferase core , 2008, Proceedings of the National Academy of Sciences.

[37]  Gang Wu,et al.  Integrative Analyses of Posttranscriptional Regulation in the Yeast Saccharomyces cerevisiae Using Transcriptomic and Proteomic Data , 2008, Current Microbiology.

[38]  DavidE . Goldberg,et al.  Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans1 , 2006, The Journal of Immunology.

[39]  S. Rosenberg,et al.  Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells , 2003, The Journal of experimental medicine.

[40]  Kristin A. Hogquist,et al.  Sweet 'n' sour: the impact of differential glycosylation on T cell responses , 2002, Nature Immunology.

[41]  A. Frey,et al.  CD8+ Tumor-Infiltrating Lymphocytes Are Primed for Fas-Mediated Activation-Induced Cell Death But Are Not Apoptotic In Situ1 , 2001, The Journal of Immunology.

[42]  S. Toyoshima,et al.  Increased Degradation of Newly Synthesized Interferon-γ (IFN-γ) in Anti CD3-Stimulated Lymphocytes Treated with Glycoprotein Processing Inhibitors , 2000 .

[43]  K Cantell,et al.  Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma. , 1994, The Biochemical journal.